This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2005:16 Suppl 8:viii13-viii19.

doi: 10.1093/annonc/mdi962.

Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens

Affiliations

PMID: 16239232
DOI: 10.1093/annonc/mdi962

Free article

Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens

T Thigpen et al. Ann Oncol. 2005.

Free article

. 2005:16 Suppl 8:viii13-viii19.

doi: 10.1093/annonc/mdi962.

Authors

Affiliation

¹ Department of Medicine, Division of Oncology, University of Mississippi Medical Center, Jackson 39216, USA. JTTHIGPEN@worldnet.att.net

PMID: 16239232
DOI: 10.1093/annonc/mdi962

No abstract available

PubMed Disclaimer

Similar articles

Clinical trials in ovarian carcinoma: study methodology.
Vermorken JB, Parmar MK, Brady MF, Eisenhauer EA, Hogberg T, Ozols RF, Rochon J, Rustin GJ, Sagae S, Verheijen RH; Gynecologic Cancer Intergroup; EORTC; MRC/NCRI; GOG; NCIC-CTG; NSGO; AGO-OVAR; JGOG. Vermorken JB, et al. Ann Oncol. 2005;16 Suppl 8:viii20-viii29. doi: 10.1093/annonc/mdi963. Ann Oncol. 2005. PMID: 16239233 No abstract available.
Management of stage I and II ovarian carcinoma.
Thigpen JT, Lambuth BW, Vance RB. Thigpen JT, et al. Semin Oncol. 1991 Dec;18(6):596-602. Semin Oncol. 1991. PMID: 1775976 Review. No abstract available.
Integration of new or experimental treatment options and new approaches to clinical trials.
Quinn M, Pfisterer J, Avall-Lundqvist E, Bookman M, Bowtell D, Casado A, Cervantes A, Grenman S, Harper P, Oza A, Pecorelli S, Pujade-Lauraine E, Trimble E, Vasey P, Wagner U; ANZGOG; AGO-OVAR; NSGO; GOG; EORTC; GEICO; MRC/NCRI; NCIC-CTG; IGCS; GINECO; NCI-US; SGCTG. Quinn M, et al. Ann Oncol. 2005;16 Suppl 8:viii30-viii35. doi: 10.1093/annonc/mdi964. Ann Oncol. 2005. PMID: 16239234 No abstract available.
The role of high-dose chemotherapy with hematopoietic stem cell support in the treatment of patients with epithelial ovarian carcinoma.
Hussein AM. Hussein AM. Cancer Invest. 1997;15(3):288-95. doi: 10.3109/07357909709039728. Cancer Invest. 1997. PMID: 9171864 Review. No abstract available.
Gynecologic Oncology Group (GOG-USA) trials in ovarian cancer.
Ozols RF. Ozols RF. Adv Exp Med Biol. 2008;622:131-43. doi: 10.1007/978-0-387-68969-2_11. Adv Exp Med Biol. 2008. PMID: 18546624 Review. No abstract available.

See all similar articles

Cited by

Clinical investigation of receptor and non-receptor tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer.
Klempner SJ, Myers AP, Mills GB, Westin SN. Klempner SJ, et al. Expert Opin Pharmacother. 2013 Nov;14(16):2171-82. doi: 10.1517/14656566.2013.826650. Epub 2013 Aug 12. Expert Opin Pharmacother. 2013. PMID: 23937415 Free PMC article. Review.
Tolerability, efficacy, and safety of pegylated liposomal Doxorubicin in combination with Carboplatin versus gemcitabine-Carboplatin for the treatment of platinum-sensitive recurrent ovarian cancer: a systematic review.
Holloway RW, Grendys EC, Lefebvre P, Vekeman F, McMeekin S. Holloway RW, et al. Oncologist. 2010;15(10):1073-82. doi: 10.1634/theoncologist.2009-0331. Epub 2010 Oct 7. Oncologist. 2010. PMID: 20930103 Free PMC article.
Treatment guidelines in ovarian cancer.
Poveda Velasco A, Casado Herráez A, Cervantes Ruipérez A, Gallardo Rincón D, García García E, González Martín A, López García G, Mendiola Fernández C, Ojeda González B; GEICO Group. Poveda Velasco A, et al. Clin Transl Oncol. 2007 May;9(5):308-16. doi: 10.1007/s12094-007-0058-8. Clin Transl Oncol. 2007. PMID: 17525041
Phase II testing of sunitinib: the National Cancer Institute of Canada Clinical Trials Group IND Program Trials IND.182-185.
Buckstein R, Meyer RM, Seymour L, Biagi J, Mackay H, Laurie S, Eisenhauer E. Buckstein R, et al. Curr Oncol. 2007 Aug;14(4):154-61. doi: 10.3747/co.2007.132. Curr Oncol. 2007. PMID: 17710208 Free PMC article.
Utility of vascular endothelial growth factor inhibitors in the treatment of ovarian cancer: from concept to application.
Amini A, Masoumi Moghaddam S, Morris DL, Pourgholami MH. Amini A, et al. J Oncol. 2012;2012:540791. doi: 10.1155/2012/540791. Epub 2011 Sep 26. J Oncol. 2012. PMID: 21961001 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information